Serum-based protein biomarkers for detection of lung cancer

Serum-based protein biomarkers for detection of lung cancer

Bibliographic Details
Main Authors:	Bhatnagar Shilpa, Katare Deepshikha, Jain Swatantra
Format:	Article
Language:	English
Published:	De Gruyter 2014-04-01
Series:	Open Life Sciences
Subjects:	lung carcinogenesis serum biomarkers cyfra 21-1 proteomic techniques
Online Access:	https://doi.org/10.2478/s11535-013-0271-0

Similar Items

Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients
by: Nikolaus A. Handke, et al.
Published: (2021-02-01)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
by: Chaiho Jeong, et al.
Published: (2021-02-01)

Comparison Study of Cyfra 21-1, Carcinoembryonic Antigen and Telomerase Activity between Non Small Cell and Small Cell Lung Cancer Patients
by: Behrang Alani, et al.
Published: (2008-12-01)

Diagnosis Value of the Detection of CYFRA21-1 in Non-small Cell Lung Cancer
by: Jundong GU, et al.
Published: (2010-12-01)

Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients
by: Xinchun DUAN, et al.
Published: (2015-06-01)

9G Test<sup>TM</sup> Cancer/Lung: A Desirable Companion to LDCT for Lung Cancer Screening
by: Wonho Choe, et al.
Published: (2020-10-01)

Combined neat model for the prognosis of postoperative stage III‐N2 non‐small cell lung cancer
by: Yirui Zhai, et al.
Published: (2020-09-01)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
by: Naghmeh Jeiroodi, et al.
Published: (2017-07-01)

Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma
by: Hitomi Takada, et al.
Published: (2021-08-01)

Clinical Significance of Serum Cytokeratin 19 Fragment in the Prediction of Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer
by: Chong'an XU, et al.
Published: (2010-10-01)

Correlation between Changes in Serum Level of CEA and CYFRA 21-1 and Objective Response of Chemotherapy
by: Xinlin MU, et al.
Published: (2009-09-01)

Multiplexed Serum Biomarkers for the Detection of Lung Cancer
by: Shenglin Ma, MD, et al.
Published: (2016-09-01)

High-Sensitivity Detection of the Lung Cancer Biomarker CYFRA21-1 in Serum Samples Using a Carboxyl-MoS2 Functional Film for SPR-Based Immunosensors
by: Nan-Fu Chiu, et al.
Published: (2020-03-01)

Role of Serum Tumor Markers in Prognosis of Operable Non-small Cell Lung Cancer Patients
by: LI Shaolei, et al.
Published: (2018-01-01)

Serum protein biomarkers for juvenile dermatomyositis: a pilot study
by: Shefa M. Tawalbeh, et al.
Published: (2020-10-01)

Serum CYFRA 21-1 in Egyptian women with breast cancer
by: Samia A. Ebied, et al.
Published: (2017-03-01)

Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder
by: Mohammad eElsayed, et al.
Published: (2012-07-01)

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study
by: Lang D, et al.
Published: (2020-12-01)

Diagnostic Significance of Combining Telomerase Activity with CYFRA21-1 Level in Differentiating Malignant Pleural Effusion Caused by Lung Cancer from Benign Pleural Effusio
by: Hongmei LI, et al.
Published: (2010-06-01)

CYFRA 21-1 in Lymph Node Fine Needle Aspiration Washout Improves Diagnostic Accuracy for Metastatic Lymph Nodes of Differentiated Thyroid Cancer
by: Jeongmin Lee, et al.
Published: (2019-04-01)

Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation
by: Preeti Singh, et al.
Published: (2017-01-01)

Measurement of Lung Cancer Tumor Markers in a Glass Wool Company Workers Exposed to Respirable Synthetic Vitreous Fiber and Dust
by: Shabnam Abtahi, et al.
Published: (2018-01-01)

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy
by: Mathieu Gauthé, et al.
Published: (2018-04-01)

Diagnostic value of cyfra 21-1 and carcinoembryonic antigen in differentiation between benign and malignant pleural effusion
by: Waffa S. El-Shimy, et al.
Published: (2015-04-01)

Comparison of CYFRA 21-1, CEA, CA 19-9 and CA 72-4 levels in gastric cancer
by: Gökhan Çakırca, et al.
Published: (2013-01-01)

The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
by: Rui Fang, et al.
Published: (2018-11-01)

Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research
by: Fukuda, T., et al.
Published: (2022)

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
by: M. G. Dal Bello, et al.
Published: (2019-03-01)

Correlation between Serum Cytokeratin 19 Fragment and the Clinicopathological Features and Prognosis of Thymic Epithelial Tumors
by: Xuefei ZHANG, et al.
Published: (2018-07-01)

Avaliação dos valores sérico e pleural dos marcadores tumorais CEA, CYFRA21-1 e CA 15-3 em portadores de derrame pleural Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion
by: Isabella Coimbra Wagner, et al.
Published: (2007-04-01)

Proteomic analysis of differentially expressed serum proteins in lung cancer
by: Bhatnagar Shilpa, et al.
Published: (2012-04-01)

Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer
by: Hua-Hsi Wu, et al.
Published: (2014-03-01)

Differential Proteomics Identification of HSP90 as Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry
by: Yiyi Sun, et al.
Published: (2010-03-01)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
by: Cao Xun, et al.
Published: (2012-09-01)

The Association of Carcinoembryonic Antigen and Cytokeratin-19 Fragments 21-1 Levels with One-Year Survival of Advanced Non-Small Cell Lung Carcinoma at Cipto Mangunkusumo Hospital: A Retrospective Cohort Study
by: Cleopas Martin Rumende, et al.
Published: (2020-08-01)

The effects of weaning stress on the serum protein profile of calves : a proteomic analysis
by: Herzog, Katie R
Published: (2007)

Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125
by: Chunjing Jin, et al.
Published: (2019-11-01)

Candidate Genes and Proteomic Biomarkers of Serum and Urine in Medication-Overuse Headache
by: Natalia A. Shnayder, et al.
Published: (2021-08-01)

Lung cancer: Clinical implications
by: Jovanović Dragana
Published: (2007-01-01)

Serum Biomarkers for Early Detection of Gynecologic Cancers
by: Yutaka Ueda, et al.
Published: (2010-06-01)